Product NDC: | 61314-665 |
Proprietary Name: | Apraclonidine |
Non Proprietary Name: | Apraclonidine |
Active Ingredient(s): | 5.75 mg/mL & nbsp; Apraclonidine |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61314-665 |
Labeler Name: | Falcon Pharmaceuticals, Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020258 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20090719 |
Package NDC: | 61314-665-05 |
Package Description: | 5 mL in 1 BOTTLE (61314-665-05) |
NDC Code | 61314-665-05 |
Proprietary Name | Apraclonidine |
Package Description | 5 mL in 1 BOTTLE (61314-665-05) |
Product NDC | 61314-665 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Apraclonidine |
Dosage Form Name | SOLUTION |
Route Name | OPHTHALMIC |
Start Marketing Date | 20090719 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Falcon Pharmaceuticals, Ltd. |
Substance Name | APRACLONIDINE HYDROCHLORIDE |
Strength Number | 5.75 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |